Sign Out
The effect of oral anticoagulants is potentiated by fenofibrate. This increases the risk of hemorrhage through the displacement of their binding with plasma protein. Therefore, initial dose therapy with fenofibrate should be reduced to 1/3 of the normal dose.
Adjustment of oral anticoagulant dose according to prothrombin time during therapy by fenofibrate and 8 days after its interruption.
